This excellent paper describes a fascinating piece of work examining an aspect of clinical trials about which we know surprisingly little. Like all good research, the answers it provides lead to additional questions for future exploration. Participants in the UK-based Taxotere as Adjuvant Chemotherapy (TACT) trial, comparing a taxane-based regimen with one of two anthracycline-containing non-taxane regimens were approached during the follow-up period, before trial results were available, to seek their preferences about dissemination of the trial results to themselves and their relatives.

More: continued here

Breast cancer natural treatment may be essential for women to recover fully from the disease. A recent study found that breast cancer survivors were less happy and suffered from more depression than women who had not had the disease. And they continued to suffer from the effects of breast cancer for years after “successful” treatment had been completed - with no end in sight.

More: continued here

Breast Cancer Awareness Month (BCAM) is a yearly international health campaign coordinated by main breast cancer charities each October to raise awareness of the disease and to inflate funds for research into its cause, prevention and cure. The campaign presents information and encouragement to those affected by breast cancer as well.

More: continued here

Inflammatory breast cancer is an accelerated type of breast cancer that is typically not identified by mammogram or ultrasound. It leads to the breast to seem swollen and inflamed. The inflammation takes place since the cancer cells blockade the lymphatic vessels in the skin of the breast. This leads to an obstruction in lymph flow causing the reddened, inflamed look to the breast.

More: continued here

Generally, when discussing concerning cancer survival rates, five-year survival is most usually used. This is for the reason that one-year survival offers simply a very short term view of prognosis and development and for ten-year survival and beyond you have to observe people identified a long time ago.

More: continued here

Radiation therapy engages employing a large machine named a linear accelerator to carry specific amounts of high-energy radiation to eradicate cancer cells. The radiation discontinues the reproduction of cancer cells at the same time as reducing damage to healthy tissues. Radiation therapy has been exposed to recover survival in women with breast cancer.

More: continued here

Breast cancer is probably one of the most feared disorders among women. This may be because cancer is the second leading cause of death among women and breast cancer is the second leading type of these cancer deaths. This article will educate you on the role that the breast biopsy procedure plays.

More: continued here

I was speaking in Milwaukee a few weeks ago to a large Komen group and a young lady, just 26 years old, came up to me and said, “I have estrogen receptor negative breast cancer…I don’t fit into the same mold as other women. So, what kinds of foods should I be eating?”

More: continued here

There are various kinds of treatment for patients with breast cancer. Many kinds of treatment are obtainable for patients with breast cancer. A number of treatments are regular (the presently applied treatment), and a number of are being examined in clinical tests. A treatment clinical test is an examination study intended to assist improve existing treatments or get information on new-fangled treatments for patients with cancer.

More: continued here

Genetic testing for inherited vulnerability for breast and ovarian cancer is the first genetic test to be marketed openly to consumers. Public health agencies might be called upon to respond issues regarding this testing from the wide-ranging public and healthcare providers in their communities. This truth sheet holds information regarding the genetic test for inherited vulnerability for breast and ovarian cancer, the clinical perspective in which it is presently employed, and a number of the possible ethical and social matters.

More: continued here